Manhattan Associates
MANH Nasdaq Application Software Financials FY2016βFY2025
Manhattan Associates' revenue rose 3.8% to $1.1 billion in fiscal 2025. Its operating margin was 25.9%, up from 25.1% a year earlier. Free cash flow was $374 million, up 30.6%. It paid out $315 million in dividends and buybacks, 84% of free cash flow. The diluted share count fell 1.8%.
About these figures. Manhattan Associates has no debt and no credit facilities (its 10-K says so), so debt is counted as zero.
What Manhattan Associates does
No business description yet.
- Legal name
- Manhattan Associates, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-26-037138
0001056696
Revenue and margins
Manhattan Associates had $1.1B of revenue in fiscal 2025, up 3.8% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 8.6% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $374M in fiscal 2025, 34.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Manhattan Associates returned $315M to shareholders in fiscal 2025, 84% of free cash flow. The diluted share count fell 1.8%.
Value Manhattan Associates yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $329M and divides by 61.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 68.4x Β· peers 44.4x Β· sector 33.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Manhattan Associates can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $264M | $226M | $271M | $266M | $329M |
| Debt incl. finance leases | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net debt / EBITDA | β1.9x | β1.4x | β1.3x | β1.0x | β1.2x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Current ratio | 1.6x | 1.3x | 1.3x | 1.3x | 1.3x |
| Quick ratio | 1.6x | 1.3x | 1.3x | 1.3x | 1.3x |
| Total assets | $540M | $570M | $673M | $758M | $839M |
| Total liabilities | $289M | $343M | $395M | $458M | $525M |
| Shareholders' equity | $251M | $227M | $278M | $299M | $315M |
| Net debt (β = net cash) | β$264M | β$226M | β$271M | β$266M | β$329M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$3.3M
3 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Eric Andrew ClarkPresident & CEO, Director | Sold | 3,000 | $197.76 | $0.6M | Form 4 |
| Aug 6, 2026 | Linda T. HollembaekDirector | Sold | 1,579 | $189.88 | $0.3M | Form 4 |
| Jul 30, 2026 | James Stewart GanttEVP, Professional Services | Sold | 5,139 | $195.53 | $1.0M | Form 4 |
| Jun 10, 2026 | Eric Andrew ClarkPresident & CEO, Director | Sold | 1,000 | $146.77 | $0.1M | Form 4 |
| Apr 24, 2026 | James Stewart GanttEVP, Professional Services | Sold | 7,300 | $139.25 | $1.0M | Form 4 |
| Nov 28, 2025 | Eric Andrew ClarkPresident & CEO, Director | Sold | 1,600 | $176.40 | $0.3M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 6 / 9 | 6 / 9 |
| Accruals ratio | β11.2% | β10.7% | β21.2% |
| Altman Z'' | 5.41 | 5.31 | 5.21 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Manhattan Associates MANH | $14.1B | 3.8% | 25.9% | 34.6% | β | 68.5x | 6 | |
| GitLab GTLB | $9.5B | 25.8% | β7.4% | 23.2% | β | β | 4 | Compare β |
| AppFolio APPF | $7.5B | 19.7% | 16.1% | 25.1% | 50.3% | 44.4x | 4 | Compare β |
| Dolby DLB | $5.9B | 5.9% | 19.6% | 32.3% | 11.4% | 26.7x | 5 | Compare β |
| Guidewire Software GWRE | $16.1B | 22.7% | 10.2% | 25.6% | 12.1% | 116.0x | 8 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $605M | $595M | $559M | $618M | $586M | $664M | $767M | $929M | $1.0B | $1.1B |
| Gross profit | $355M | $349M | $318M | $333M | $317M | $366M | $409M | $498M | $571M | $609M |
| Research and development | $54.7M | $57.7M | $71.9M | $87.6M | $84.3M | $97.6M | $112M | $127M | $138M | $145M |
| Operating income | $194M | $186M | $134M | $116M | $114M | $134M | $153M | $210M | $262M | $280M |
| Pretax income | $196M | $185M | $136M | $116M | $114M | $134M | $158M | $214M | $267M | $286M |
| Income tax | $71.9M | $68.4M | $31.5M | $30.3M | $26.5M | $23.6M | $29.2M | $37.1M | $48.4M | $65.9M |
| Net income | $124M | $117M | $105M | $85.8M | $87.2M | $111M | $129M | $177M | $218M | $220M |
| Diluted EPS | $1.72 | $1.68 | $1.58 | $1.32 | $1.36 | $1.72 | $2.03 | $2.82 | $3.51 | $3.60 |
| Diluted shares | 0.07B | 0.07B | 0.07B | 0.07B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $139M | $164M | $137M | $147M | $141M | $185M | $180M | $246M | $295M | $390M |
| Capital expenditure | $6.8M | $6.2M | $7.3M | $15.2M | $2.7M | $4.0M | $6.6M | $4.7M | $8.7M | $15.5M |
| Free cash flow | $133M | $158M | $130M | $132M | $138M | $181M | $173M | $241M | $286M | $374M |
| Depreciation and amortization | $9.1M | $9.1M | $8.6M | $8.0M | $8.9M | $7.9M | $6.7M | $5.8M | $6.3M | $6.3M |
| Stock-based compensation | $15.9M | $16.2M | $19.9M | $31.8M | $33.4M | $43.3M | $59.4M | $71.6M | $93.2M | $111M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $168M | $132M | $149M | $122M | $43.6M | $120M | $205M | $196M | $286M | $315M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $168M | $132M | $149M | $121M | $43.6M | $120M | $204M | $196M | $286M | $315M |
| Balance sheet | ||||||||||
| Cash and short-term investments | β | $126M | $101M | $111M | $205M | $264M | $226M | $271M | $266M | $329M |
| Total debt | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $207M | $228M | $215M | $232M | $334M | $408M | $415M | $479M | $503M | $583M |
| Current liabilities | $118M | $124M | $145M | $182M | $197M | $249M | $316M | $366M | $400M | $456M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $17.4M | $15.5M | $14.3M | $22.7M | $17.9M | $13.9M | $12.8M | $11.8M | $14.0M | $23.1M |
| Total assets | $297M | $315M | $307M | $372M | $465M | $540M | $570M | $673M | $758M | $839M |
| Total liabilities | $128M | $140M | $160M | $230M | $247M | $289M | $343M | $395M | $458M | $525M |
| Shareholders' equity | $169M | $175M | $147M | $142M | $219M | $251M | $227M | $278M | $299M | $315M |
| Margins | ||||||||||
| Gross margin | 58.7% | 58.7% | 56.9% | 53.9% | 54.0% | 55.1% | 53.3% | 53.6% | 54.8% | 56.3% |
| Operating margin | 32.1% | 31.2% | 23.9% | 18.8% | 19.5% | 20.2% | 19.9% | 22.6% | 25.1% | 25.9% |
| EBITDA margin | 33.6% | 32.8% | 25.5% | 20.1% | 21.0% | 21.4% | 20.8% | 23.2% | 25.7% | 26.5% |
| Net margin | 20.6% | 19.6% | 18.7% | 13.9% | 14.9% | 16.7% | 16.8% | 19.0% | 21.0% | 20.3% |
| FCF margin | 21.9% | 26.6% | 23.3% | 21.3% | 23.6% | 27.3% | 22.6% | 26.0% | 27.5% | 34.6% |
| Returns | ||||||||||
| Return on capital | β | β | 214.3% | 219.1% | β | β | β | β | β | β |
| Return on capital employed | 101.1% | 100.3% | 75.9% | 65.8% | 49.7% | 48.1% | 56.0% | 74.7% | 78.7% | 75.6% |
| Return on equity | 68.1% | 67.7% | 65.0% | 59.3% | 48.3% | 47.1% | 54.0% | 69.9% | 75.6% | 71.7% |
| Return on assets | 39.5% | 38.1% | 33.7% | 25.3% | 20.8% | 22.0% | 23.2% | 28.4% | 30.5% | 27.6% |
| Growth | ||||||||||
| Revenue growth | 360.4% | β1.7% | β6.0% | 10.5% | β5.1% | 13.2% | 15.6% | 21.1% | 12.2% | 3.8% |
| Net income growth | 20.1% | β6.2% | β10.1% | β18.1% | 1.7% | 26.6% | 16.7% | 36.9% | 23.7% | 0.7% |
| EPS growth | 22.9% | β2.3% | β6.0% | β16.5% | 3.0% | 26.5% | 18.0% | 38.9% | 24.5% | 2.6% |
| FCF growth | 21.9% | 19.1% | β17.6% | 1.3% | 4.9% | 31.1% | β4.5% | 39.6% | 18.6% | 30.6% |
| Share count change | β2.7% | β3.7% | β4.3% | β2.0% | β1.2% | β0.0% | β1.4% | β1.3% | β0.7% | β1.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β0.6x | β0.7x | β0.9x | β1.7x | β1.9x | β1.4x | β1.3x | β1.0x | β1.2x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Current ratio | 1.8x | 1.8x | 1.5x | 1.3x | 1.7x | 1.6x | 1.3x | 1.3x | 1.3x | 1.3x |
| Quick ratio | 1.8x | 1.8x | 1.5x | 1.3x | 1.7x | 1.6x | 1.3x | 1.3x | 1.3x | 1.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.1% | 1.0% | 1.3% | 2.5% | 0.5% | 0.6% | 0.9% | 0.5% | 0.8% | 1.4% |
| Stock comp / revenue | 2.6% | 2.7% | 3.6% | 5.2% | 5.7% | 6.5% | 7.7% | 7.7% | 8.9% | 10.3% |
| Payouts / FCF | 126.7% | 83.4% | 114.8% | 92.2% | 31.5% | 66.5% | 118.2% | 81.2% | 100.0% | 84.3% |
| Quality scores | ||||||||||
| Piotroski F-score | 7.0 | 8.0 | 4.0 | 5.0 | 6.0 | 6.0 | 5.0 | 7.0 | 6.0 | 6.0 |
| Altman Z'' | 9.8 | 9.4 | 7.1 | 5.0 | 6.2 | 6.2 | 5.1 | 5.4 | 5.3 | 5.2 |
| Accruals ratio | β4.8% | β15.6% | β10.5% | β18.0% | β12.8% | β14.9% | β9.1% | β11.2% | β10.7% | β21.2% |
Source: SEC EDGAR XBRL filings (CIK 0001056696). Data updated October 16, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.